Biosimilar Insights
-
The AI Impact with Generate:Biomedicines' Mike Nally
3/24/2024
Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artificial intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Generate: Biomedicines, which bills itself at the "intersection of machine learning, biological engineering, and medicine."
-
Three Key Considerations For Optimizing Process Development
3/21/2024
When it comes to process development, timing, technology, and partners all merit careful consideration. Explore expert insights into these three crucial factors.
-
Navigating Cell Therapy Process Development
3/21/2024
Explore the main challenges and considerations inherent in cell therapy process development.
-
Get Full Control Of Your T Cell Isolation
3/21/2024
This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application.
-
Formulation Process And Analytical Development Capabilities
3/21/2024
Explore process and analytical development capabilities that can help you advance your formulation to GMP Manufacturing.
-
Advancing A LNP Formulation To Clinical And Commercial Manufacturing
3/21/2024
Lipid selection impacts the final LNP drug product and the LNP process. Review critical quality considerations for lipids and the process requirements for successful commercial-scale manufacturing.
-
Top 10 Biologics Approved In 2023
3/20/2024
In 2023, 18 new biologic drugs were approved by the EMA and 34 by the FDA. Dive into the 10 most important drugs that cover unmet medical needs and have the highest potential to revolutionize medical practice.
-
Four Steps To Identifying The CDMO Proposal Worth Signing
3/19/2024
The leap from sending your RFPs to choosing a CDMO partner requires the ability to think critically about the red flags and green flags of a given proposal.
-
Building Biopharma Resilience In Developing Gene Therapies
3/18/2024
Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia, difficulties with the talent pipeline, and more.
-
Biopharmaceuticals: State Of The Industry
3/18/2024
How are government policies, talent pools, and supply chain constraints affecting the state of the industry? Learn about the biopharma industry’s biggest strengths, greatest challenges, and much more.